U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07579754) titled 'BetterInfo on Women's PrEP Choices and Outcomes in Malawi' on April 30.
Brief Summary: The purpose of this study is to understand PrEP user choices, preferences and implementation impact of the roll-out of long-acting injectable PrEP alongside oral PrEP among women in Blantyre, Malawi.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Long-acting Injectable Cabotegravir for PrEP
Oral Pre-Exposure Prophylaxis (PrEP)
Intervention:
BEHAVIORAL: Tracing Strategy
Participants will receive the SoC per national guidelines and the tracing strategy. The purpose of this intervention is to ascertain the PrEP outcome of cli...